Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Barata, Fernando [1 ]
Sousa, Amelia [2 ]
Camacho, Elvira [3 ]
Costa, Marco S. [4 ]
Canario, Dolores [5 ]
Nogueira, Fernando [6 ]
Semedo, Eulalia [7 ]
机构：
[1] Ctr Hosp Coimbra, Unidade Pneumol, Coimbra, Portugal
[2] Hosp Univ Coimbra, Serv Pneumol, Coimbra, Portugal
[3] Hosp Nossa Senhora do Rosario, Serv Pneumol, Barreiro, Portugal
[4] Hosp Dist Santarem, Serv Pneumol, Santarem, Portugal
[5] Hosp Garcia Dorta, Serv Pneumol, Almada, Portugal
[6] Hosp Egas Moniz, Serv Pneumol, Lisbon, Portugal
[7] Hosp S Bernardo, Serv Pneumol, Setubal, Portugal
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [41] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    [J]. ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [42] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [43] Sequential cisplatin-gemcitabine-docetaxel vs docetaxel-gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Interim results of an ongoing phase II trial.
    Binder, D
    Beinert, T
    Schweisfurth, H
    Grah, C
    Temmesfeld-Wollbrock, B
    Müller-Hagen, G
    Schäper, C
    Schürmann, D
    Suttorp, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 644S - 644S
  • [44] Efficacy and safety of docetaxel plus oxaliplatin as a first-line chemotherapy in patients with advanced or metastatic non-small cell lung cancer
    Ban, Heejung
    Kim, Kyu-Sik
    Oh, In-Jae
    Yoon, Seong-Hoon
    Lee, Boram
    Yu, Jinyeong
    Kim, Sunmin
    Lee, Ho-Sung
    Shin, Hong-Joon
    Park, Cheol-Kyu
    Kwon, Yong-Soo
    Kim, Yu-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    [J]. THORACIC CANCER, 2014, 5 (06) : 525 - 529
  • [45] Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)
    Zalcberg, JR
    Bishop, JF
    Millward, MJ
    Zimet, A
    Laird, J
    Barter, C
    Seward, D
    McKeage, MJ
    Friedlander, ML
    Toner, G
    Berille, J
    Blanc, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1084 - 1084
  • [46] Nedaplatin or Oxaliplatin Combined with Paclitaxel and Docetaxel as First-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer
    Zhang, Keqian
    Qin, Hong
    Pan, Feng
    Liu, Enqiang
    Liang, Houjie
    Ruan, Zhihua
    [J]. MEDICAL SCIENCE MONITOR, 2014, 20 : 2830 - 2836
  • [47] A Study of Endostar Combined with Gemcitabine in the First-Line Treatment of the Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Chen, Qun
    She, Qin
    Xie, Qiang
    Xiao, Song
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S889 - S890
  • [48] Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer
    Montalar, J
    Morales, S
    Maestu, I
    Camps, C
    Vadell, C
    García, R
    Yuste, AL
    Torregrosa, D
    Segura, A
    [J]. LUNG CANCER, 2001, 34 (02) : 305 - 311
  • [49] Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC)
    Binder, D.
    Hackenthal, M.
    Graseck, L.
    Schweisfurth, H.
    Schaeper, C.
    Kruell, M.
    Temmesfeld-Wollbrueck, B.
    Suttorp, N.
    Beinert, T.
    Hellriegel, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] PROSPECTIVE PHASE II TRIAL OF A COMBINATION OF GEMCITABINE AND UFT AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Baek, J. H.
    Kim, H.
    Kim, H. J.
    Park, J.
    Min, Y. J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
12345